Prof. Yigal Shoshann

Director of the Department of Neurosurgery

AREAS OF INTEREST

  • Augmented virtual reality
  • Genetics of brain tumors
  • Pathophysiology of head injuries
  • Intra-operational navigation
  • Robotics

 

 

  • MD Cum-Laude from the Israel Institution of Technology Medical School, 1987
  • Neurosurgery Residency, Hadassah University Hospital, Jerusalem, 1989-1995
  • Staff Neurosurgeon, Hadassah University Hospital, Jerusalem since 1995
  • Lecturer in Neurosurgery, Hebrew University Medical School, since 1995
  • Research Fellow, The Molecular Genetic Center at the Lerner Research Institution of the Cleveland Clinic Foundation, Cleveland, Ohio, 1997
  • Research Fellow, Department of Neurosciences at the Lerner Research Institution of the Cleveland Clinic Foundation, Cleveland, Ohio, 1998
  • Clinical Fellow, Neuro-oncology/stereotactic & Gamma Knife Radiosurgery Department of neurological surgery, Cleveland Clinic Foundation, Cleveland, Ohio, 1998-1999
  • Visiting Professor at the LINAC – based Radiosurgery unit in New Jersey state University Hospital, (UMDNJ), 2000

 

CLINICAL RESEARCH

 

  • Safety of preoperative minidose heparin in brain tumor surgery: a prospective, randomized, double-masked Phase II study. Co-investigator
  • The Ciba-Geigy Head Injury Trial with CGS-19755 (Selfotel).  Co- investigator
  • The International Blood Brain Barrier Disruption Program. Co-investigator
  • Safety evaluation of a single IV dose of Dexanabinol (HU 211) in patients suffering from severe head injury – National multicenter Phase II study (Pharmos Corporation).   Principal investigator.
  • Efficacy and safety evaluation of a single IV dose of Dexanabinol (HU 211) in patients suffering from sever head injury – International multicenter Phase III study, (Pharmos Corporation).   Principal investigator.

 

BASIC RESEARCH EXPOSURE

 

  • 1993-4  Neurooncology laboratory – “The effect of super oxide dismutase on peritumoral brain edema in rat brain tumor model ”with Prof. Tali Siegal.
  • 1995 The Blood Brain Barrier Disruption Program for intraarterial administration of chemotherapy, Portland/Oregon with Dr. Ed Neuwelt.
  • 1997  Research program in the field of molecular Genetics – John K Cowell Ph.D. “ Gene rearrangement on chromosome 10 in GBM”, and “Molecular analyses of radiation –induced meningiomas”. The Molecular Genetic Center, The Lerner Research Institute, Cleveland Clinic Foundation.
  • 1998  Research in the field of cell biology and development- Bruce D Trapp Ph.D. “Expression of oligodendrocyte progenitor cell antigens by gliomas: Implications for the histogenesis of brain tumors” Department of Neurosciences, The Lerner Research Institute, Cleveland Clinic Foundation.

 

NEUROSURGICAL CERTIFICATIONS

 

  • Israeli Board in Neurosurgery. Specialist’s License No. 20906  -1994
  • European Association of Neurological Surgeons (EANS) Certificate  – 1996

 

OTHER CERTIFICATIONS

 

  • ECFMG Certification #: 0-421-215-5  – 1995
  • FLEX Certification #: 560414020 – 1993

 

MEMBERSHIPS – SCIENTIFIC AND PROFESSIONAL SOCIETIES.

 

Active Memberships

 

  • Israeli Medical Association since 1989
  • Israeli Neurosurgical Society since 1995
  • Israeli Neurotrauma Society since 1995
  • Israeli Surgical Society since 1996
  • Israeli Neurosciences Society since 1997
  • The American Association of Neurological Surgeon  (AANS) since 1999
  • The Congress of Neurological Surgeon  (CNS) since 1999
  • The Tumor Section of the AANS since 1999
  • The Society for Neuro-Oncology since 2002

 

 

HONORS AND AWARDS

 

  • Dean’s Honor list of medical Sciences, Technion 1981,1982, 1983, 1984
  • Technion – Israel Institution of Technology Medical School  – Cum Laude  – 1987
  • Recipient of the best paper award at the 24th neuroscience resident/fellows’ day, The Cleveland Clinic Foundation, 1999, “molecular genetic analyses of radiation-Induced meningiomas”.

 

 

GRANTS FOR RESEARCH

 

  • The Hebrew University and Hadassah University Hospital research grant laboratory study on brain tumor model. 1993 & 1994, 5000$ for each year. Partner – Prof. Tali Siegal.
  • The Israeli Chief Scientist of Ministry of Health Stipend for experimental studies on the effect of superoxide dismutase on peritumoral brain  edema  in  rat brain tumor model. 1995 & 1996 (40,000$ each year). Partner – Prof. Tali Siegal.

download almost uapkmod here | the best resources android apps on uapkmod.com